KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Operating Leases (2019 - 2026)

Pacific Biosciences Of California has reported Operating Leases over the past 7 years, most recently at $57.0 million for Q4 2025.

  • For Q4 2025, Operating Leases rose 282.46% year-over-year to $57.0 million; the TTM value through Dec 2025 reached $57.0 million, up 282.46%, while the annual FY2025 figure was $57.0 million, 282.46% up from the prior year.
  • Operating Leases for Q4 2025 was $57.0 million at Pacific Biosciences Of California, up from $54.3 million in the prior quarter.
  • Over five years, Operating Leases peaked at $57.0 million in Q4 2025 and troughed at $14.9 million in Q4 2024.
  • A 5-year average of $37.0 million and a median of $36.6 million in 2023 define the central range for Operating Leases.
  • Biggest five-year swings in Operating Leases: plummeted 53.34% in 2021 and later skyrocketed 282.46% in 2025.
  • Year by year, Operating Leases stood at $50.0 million in 2021, then fell by 17.81% to $41.1 million in 2022, then dropped by 23.04% to $31.6 million in 2023, then tumbled by 52.81% to $14.9 million in 2024, then skyrocketed by 282.46% to $57.0 million in 2025.
  • Business Quant data shows Operating Leases for PACB at $57.0 million in Q4 2025, $54.3 million in Q3 2025, and $52.9 million in Q1 2025.